Unilateral radiotherapy for the treatment of tonsil cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 204-209

  Chronowski, Gregory M ^a   Garden, Adam S ^a   Morrison, William H ^a   Frank, Steven J ^a   Schwartz, David L ^b   Shah, Shalin J ^a   Beadle, Beth M ^a   Gunn, G Brandon ^a   Kupferman, Michael E ^a   Ang, Kian K ^a   Rosenthal, David I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Long Island Jewish Hospital   (United States)

Author keywords

Failure; Neck; Radiotherapy; Tonsil; Unilateral

Indexed keywords

ACUTE TOXICITY; ANDERSONS; CERVICAL LYMPH NODES; CLINICAL OUTCOME; DISEASE FREE SURVIVAL; GASTROSTOMY; HIGH RATE; LOCOREGIONAL CONTROL; LOW RATES; NECK; OVERALL SURVIVAL; SECOND PRIMARY TUMORS; SOFT PALATES; SQUAMOUS CELL CARCINOMA; TONSIL; UNILATERAL;

BODY FLUIDS; COMPUTER SYSTEM RECOVERY; DISEASES; DISSECTION;

RADIOTHERAPY;

CETUXIMAB; CISPLATIN;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ELECTRON THERAPY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; NUTRITIONAL SUPPORT; OVERALL SURVIVAL; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SOFT PALATE; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; TONSILLECTOMY; TUMOR LOCALIZATION; UNILATERAL RADIOTHERAPY;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; SURVIVAL RATE; TONSILLAR NEOPLASMS; TONSILLECTOMY;

EID: 84859857898     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.1975     Document Type: Article

References (17)

1. B. O'Sullivan, P. Warde, and B. Grice The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region Int J Radiat Oncol Biol Phys 51 2001 332 343
2. M.D. Leslie, and S. Dische The early changes in salivary gland function during and after radiotherapy given for head and neck cancer Radiother Oncol 30 1994 26 32
3. R. Corvo, F. Foppiano, and A. Bacigalupo Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: Technical methodology and preliminary results Tumori 90 2004 66 72
4. D.I. Rosenthal, J.A. Asper, and J.L. Barker Jr. Importance of patient examination to clinical quality assurance in head and neck radiation oncology Head Neck 28 2006 967 973
5. S.M. Jackson, J.H. Hay, and A.D. Flores Cancer of the tonsil: The results of ipsilateral radiation treatment Radiother Oncol 51 1999 123 128
6. K.E. Rusthoven, D. Raben, and C. Schneider Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: Results of a prospective management approach Int J Radiat Oncol Biol Phys 74 2009 1365 1370
7. M.P. Vallis, J. Cleeland, and P.J. Bradley Radiation therapy of squamous carcinoma of the tonsil: An analysis of prognostic factors and of treatment failures Br J Radiol 59 1986 251 256
8. A.P. Jellema, B.J. Slotman, and P. Doornaert Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva Radiother Oncol 85 2007 83 89
9. K. Bjordal, A. de Graeff, and P.M. Fayers A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group Eur J Cancer 36 2000 1796 1807
10. A.S. Garden, W.H. Morrison, and P.F. Wong Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 67 2007 438 444
11. K.K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
12. M.L. Gillison HPV and prognosis for patients with oropharynx cancer Eur J Cancer 45 Suppl. 1 2009 383 385
13. A.S. Garden, J.A. Asper, and W.H. Morrison Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer 100 2004 1171 1178
14. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
15. F. Denis, P. Garaud, and E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
16. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
17. J. Chavaudra, and A. Bridier [Definition of volumes in external radiotherapy: ICRU reports 50 and 62] Cancer Radiother 5 2001 472 478